National Institutes of Health to Grant Exclusive License for Nitrite Therapy for Cardiovascular Conditions

Summary

The National Institutes of Health is considering granting an exclusive license to Hope Medical Enterprises, Inc. to use nitrite salts for treating cerebral vasospasm and cardiovascular conditions, following the filing of PCT patent applications in 2004.